JPM vs MPB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Mid Penn Bancorp exhibits a stable financial profile with a Piotroski F-Score of 4/9 and significant valuation upside, as the current price of $33.43 sits well below both the Graham Number ($44.39) and the Intrinsic Value ($73.16). The company is trading at a discount to book value (P/B 0.95) while delivering aggressive revenue growth of 33.10% YoY, likely fueled by recent merger activity. Despite a heavily bearish technical trend (10/100), the fundamental data—including a low forward P/E of 8.35 and a consistent history of earnings beats—suggests a strong value opportunity.
Compare Another Pair
Related Comparisons
JPM vs MPB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Mid Penn Bancorp, Inc. (MPB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.